H. Wernze

779 total citations
60 papers, 560 citations indexed

About

H. Wernze is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, H. Wernze has authored 60 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 16 papers in Hepatology and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in H. Wernze's work include Liver Disease and Transplantation (16 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hormonal Regulation and Hypertension (8 papers). H. Wernze is often cited by papers focused on Liver Disease and Transplantation (16 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hormonal Regulation and Hypertension (8 papers). H. Wernze collaborates with scholars based in Germany, United Kingdom and Estonia. H. Wernze's co-authors include H Schweisfurth, M. Goerig, R Arendt, G. Paumgartner, Christiane Falge, K. Weigand, Alexander L. Gerbes, Tilman Sauerbruch, Edmund Purucker and W Burghardt and has published in prestigious journals such as Nature, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

H. Wernze

59 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Wernze Germany 13 211 128 115 110 106 60 560
J.M. Gaya Spain 13 199 0.9× 149 1.2× 62 0.5× 70 0.6× 188 1.8× 45 648
Abraham Borkowski Belgium 14 48 0.2× 67 0.5× 130 1.1× 264 2.4× 125 1.2× 33 845
I. Colina Spain 8 114 0.5× 211 1.6× 84 0.7× 63 0.6× 41 0.4× 10 555
María Casadevall Spain 13 344 1.6× 229 1.8× 39 0.3× 41 0.4× 26 0.2× 17 554
Helle C. Thiesson Denmark 15 59 0.3× 65 0.5× 53 0.5× 125 1.1× 165 1.6× 47 700
Ethan P. Carter United States 11 148 0.7× 55 0.4× 40 0.3× 22 0.2× 247 2.3× 14 604
Ping‐sheng Wu China 11 45 0.2× 61 0.5× 92 0.8× 82 0.7× 18 0.2× 28 363
Elisabeth Lasnier France 15 329 1.6× 464 3.6× 38 0.3× 56 0.5× 81 0.8× 36 1.0k
Ning Yang China 17 71 0.3× 121 0.9× 43 0.4× 249 2.3× 53 0.5× 40 720
Jeroen Nijhuis Netherlands 7 117 0.6× 384 3.0× 87 0.8× 100 0.9× 23 0.2× 9 692

Countries citing papers authored by H. Wernze

Since Specialization
Citations

This map shows the geographic impact of H. Wernze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Wernze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Wernze more than expected).

Fields of papers citing papers by H. Wernze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Wernze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Wernze. The network helps show where H. Wernze may publish in the future.

Co-authorship network of co-authors of H. Wernze

This figure shows the co-authorship network connecting the top 25 collaborators of H. Wernze. A scholar is included among the top collaborators of H. Wernze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Wernze. H. Wernze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wernze, H.. (2016). Hypalgesie bei Bulimie. MMW - Fortschritte der Medizin. 158(3). 57–59. 1 indexed citations
2.
Wernze, H. & Thomas Herdegen. (2014). Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series. Scandinavian Journal of Pain. 5(2). 63–71. 6 indexed citations
3.
Hüppe, Michael, et al.. (2009). Treatment of patients burdened with lipophilic toxicants: A randomized controlled trial. 2 indexed citations
4.
Wernze, H., et al.. (2008). Angioneurotisches Ödem durch Angiotensin-Konversionsenzym-Hemmer. DMW - Deutsche Medizinische Wochenschrift. 117(19). 727–732. 1 indexed citations
5.
Burghardt, W & H. Wernze. (2008). Abdominelle Sonographie bei hereditärem angioneurotischem Ödem. Ultraschall in der Medizin - European Journal of Ultrasound. 8(6). 278–282. 1 indexed citations
6.
Peter, Michael, Wolfgang G. Sippell, & H. Wernze. (1993). Diagnosis and treatment of 17-hydroxylase deficiency. The Journal of Steroid Biochemistry and Molecular Biology. 45(1-3). 107–116. 19 indexed citations
7.
Gerbes, Alexander L., et al.. (1989). Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis†. Hepatology. 9(3). 417–422. 60 indexed citations
8.
Goerig, M., H. Wernze, B Kommerell, & M Grün. (1989). Increased bioavailability of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after portacaval shunting. Hepatology. 10(2). 154–162. 7 indexed citations
9.
Wernze, H., et al.. (1988). Drug-Induced Changes in Prolactin Secretion. PubMed. 3(6). 463–498. 8 indexed citations
10.
Wernze, H., et al.. (1988). Plasma free and sulfoconjugated catecholamines during acute asphyxia in the sheep fetus — relation to cardiovascular parameters. Journal of Perinatal Medicine. 16(2). 113–122. 6 indexed citations
11.
Gerbes, Alexander L., R Arendt, R. Gerzer, et al.. (1988). Role of atrial natriuretic factor, cyclic GMP and the renin–aldosterone system in acute volume regulation of healthy human subjects. European Journal of Clinical Investigation. 18(4). 425–429. 27 indexed citations
12.
Ertl, Georg, et al.. (1983). Alpha-receptor restriction of coronary blood flow during atrial fibrillation. The American Journal of Cardiology. 52(7). 887–892. 21 indexed citations
13.
Schweisfurth, H & H. Wernze. (1979). Changes of serum angiotensin I converting enzyme in patients with viral hepatitis and liver cirrhosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(3). 207–10. 29 indexed citations
14.
Wernze, H. & W Burghardt. (1979). [Hyperprolactinemia in liver diseases. Occurrence, clinical significance, etiology].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 74(44). 1615–23. 1 indexed citations
15.
Wernze, H., et al.. (1978). Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. Journal of Molecular Medicine. 56(8). 389–397. 66 indexed citations
16.
Wernze, H., et al.. (1977). Plasma prolactin and prolactin release in liver cirrhosis.. PubMed. 24(2). 97–101. 12 indexed citations
17.
Weigand, K., H. Wernze, & Christiane Falge. (1977). Synthesis of angiotensinogen by isolated rat liver cells and its regulation in comparison to serum albumin. Biochemical and Biophysical Research Communications. 75(1). 102–110. 42 indexed citations
18.
Erbler, H. C., et al.. (1976). Effect of the aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man. European Journal of Clinical Pharmacology. 9(4). 253–257. 6 indexed citations
19.
Weigand, K., H. Wernze, & Christiane Falge. (1974). Proceedings: Properties of enzymatically isolated rat liver cells in the ficoll gradient.. PubMed. 355(10). 1266–1266. 1 indexed citations
20.
Wernze, H. & Jun Fujii. (1966). [Hepatic inactivation and pressor action of angiotensin].. PubMed. 140(2). 128–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.M. Gaya Breakdown of academic impact, for papers by Abraham Borkowski Breakdown of academic impact, for papers by I. Colina Breakdown of academic impact, for papers by María Casadevall Breakdown of academic impact, for papers by Helle C. Thiesson Breakdown of academic impact, for papers by Ethan P. Carter Breakdown of academic impact, for papers by Ping‐sheng Wu Breakdown of academic impact, for papers by Elisabeth Lasnier Breakdown of academic impact, for papers by Ning Yang Breakdown of academic impact, for papers by Jeroen Nijhuis
Rankless by CCL
2026